Our Studies

Is asthma preventing you from breathing easy? If you are diagnosed with asthma and it makes it harder for you to breathe, you could be eligible to participate in this clinical trial.

To qualify, you must meet the following criteria:

• You are 18 to 80 years of age

• You are at a high risk for asthma attacks

• You are losing lung function

• You are having trouble controlling your asthma due to inflammation in your lungs

• You must not be a current smoker

The investigational study treatment will be administered by injection under the skin at our clinic in West Vancouver. The study will last around one year, and you will attend appointments at the clinic at every 4 weeks to receive the investigational study medication and for a check-up with our physicians and study team. The study drug will be provided at no cost to you. The aim of the study is to determine if the investigational drug can improve symptoms for individuals who have a type of asthma that puts them at high risk for attacks.

Is asthma making it hard to catch your breath? If you have eosinophilic asthma and are currently receiving medical care for your asthma, you could be eligible to participate in this clinical trial. To qualify, you must meet the following criteria:

• You are between the ages of 12 to 75

• You have a confirmed diagnosis of eosinophilic asthma

• You have been treated with inhaled steroids

• You have been treated with a long-acting asthma medication for at least 1 year

• You are not a current smoker, or have stopped smoking more than 6 months ago

The investigational study treatment will be administered by injection under the skin at our clinic in Kamloops. The total duration of the study is 57 weeks. Initially, you will receive injections every 4 weeks for the first 3 treatments, followed by injections every 8 weeks. Throughout this period, you will have regular check-ups with our physicians and study team. The study drug will be provided at no cost to you. The aim of the study is to determine if the investigational drug can benefit individuals with eosinophilic asthma.

Click “Apply now” and one of our researchers will be in contact with you to discuss your eligibility.

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart attack or stroke. The study drug will be administered subcutaneously (SC) (under the skin).

For more information: https://clinicaltrials.gov/study/NCT06292013 

The NAZARE Study is a clinical trial looking into a new investigational medication (anti-TSLP antibody) that may offer a different approach to managing uncontrolled asthma. The investigational study medication is given by injection and works by targeting the underlying inflammation that contributes to asthma symptoms.

This study may be suitable for you if you:

• Are between 18 and 75 years old
• Have been diagnosed with asthma for at least 12 months
• Are currently taking medium or high-dose ICS + at least one additional controller medication
• Have experienced one or more asthma exacerbations in the past 12 months (e.g., ER visit, hospitalization, or steroid use)

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart attack or stroke. The study drug will be administered subcutaneously (SC) (under the skin).

More information: https://clinicaltrials.gov/study/NCT06292013 

Is asthma preventing you from breathing easy? If you are diagnosed with asthma and it makes it harder for you to breathe, you could be eligible to participate in this clinical trial.

To qualify, you must meet the following criteria:

• You are 18 to 80 years of age

• You are at a high risk for asthma attacks

• You are losing lung function

• You are having trouble controlling your asthma due to inflammation in your lungs

• You must not be a current smoker

The investigational study treatment will be administered by injection under the skin at our clinic in West Vancouver. The study will last around one year, and you will attend appointments at the clinic at every 4 weeks to receive the investigational study medication and for a check-up with our physicians and study team. The study drug will be provided at no cost to you. The aim of the study is to determine if the investigational drug can improve symptoms for individuals who have a type of asthma that puts them at high risk for attacks.